期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Effect of primary prevention of implantable cardioverter defibrillator on sudden cardiac death in 24 patients with dilated cardiomyopathy
1
作者 弓旭东 《China Medical Abstracts(Internal Medicine)》 2017年第1期32-33,共2页
Objective To study the effect of primary prevention of implantable cardioverter defibrillator(ICD)on sudden cardiac death(SCD)in patients with dilated cardiomyopathy.Methods A total of 36 patients with dilated cardiom... Objective To study the effect of primary prevention of implantable cardioverter defibrillator(ICD)on sudden cardiac death(SCD)in patients with dilated cardiomyopathy.Methods A total of 36 patients with dilated cardiomyopathy treated in our hospital from 2013-12 to2014-12 were studied including 29(80.6%)male and 7(19.4%)female with the mean age of(63±11.8) 展开更多
关键词 LVEF Effect of primary prevention of implantable cardioverter defibrillator on sudden cardiac death in 24 patients with dilated cardiomyopathy
原文传递
Results of transvenous lead extraction of coronary sinus leads in patients with cardiac resynchronization therapy 被引量:1
2
作者 Christoph T. Starck Starck, Etem Caliska +3 位作者 Holger Klein Jan Steffel Felix Schoenrath Volkmar Falk 《Chinese Medical Journal》 SCIE CAS CSCD 2013年第24期4703-4706,共4页
Background The need for transvenous lead extraction procedures of coronary sinus (CS) leads is increasing due to rising numbers of implanted cardiac resynchronization therapy devices during the past decade. Methods ... Background The need for transvenous lead extraction procedures of coronary sinus (CS) leads is increasing due to rising numbers of implanted cardiac resynchronization therapy devices during the past decade. Methods From January 2009 to June 2013, 27 CS leads were scheduled for extraction in 27 patients (mean age (63.1±14.6) years). Indications for lead extraction were infection in 13 and lead dysfunction in 14 cases. Isolated extraction of CS leads was performed in eight, extraction of multiple leads in 19 cases. Among leads with an implant time of 〉12 months (n=19) mean implant duration (MID) was (46.4±15.2) (12-76) months. Groups were formed depending on infectious or non-infectious indications (INF vs. Non-INF), and the use or non-use of extraction tools (ET1 vs. ET0). Results Among patients with an implant duration of 〉12 months, complete procedural success was 94.7% and clinical success 100%. Operative mortality was zero. In the INF versus NON-INF groups complete procedural success (100% vs. 91.7%, P=0.43), mean number of required extraction tools (0.7 (0-2) vs. 0.9 (0-3), P=0.65) and MID (49.1±15.0 vs. 44.7±15.8, P=0.83) did not differ significantly. Comparing the groups ET1 and ET0 showed no significant differences in complications (n=l vs. n=l, P=-0.81) and MID (47.0±17.5 vs. 45.5±12.6, P=0.71). Conclusions In specialized centers transvenous lead extraction of coronary sinus leads with a mean implant duration of almost four years can be performed safely and effectively. Neither non-infectious indications nor the use of extraction tools negatively affected the outcome of the procedure. 展开更多
关键词 lead extraction coronary sinus leads PACEMAKER implantable cardioverter defibrillator cardiac resynchronization therapy
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部